Physiologically‐based pharmacokinetic modeling of renally excreted antiretroviral drugs in pregnant women

Abstract

Pregnancy PBPK models are useful tools to quantify a priori the drug exposure changes during pregnancy for renally excreted drugs. These models can be applied to evaluate alternative dosing regimens to optimize drug therapy during pregnancy.